Similarity between LGL-associated clonotypes
Patient . | VB . | CDR3 . | JB . | % clonal frequency . |
---|---|---|---|---|
27 | 13 | ASSVPGGEQYF | 2-7 | Minor |
50 | 13 | ASSVPGGEQYF | 2-7 | 48 |
54 | 13 | ASSVPGGEQYF | 2-7 | 43 |
27 | 13 | ASSYYREPQHFGD | 1-5 | Minor |
50 | 13 | ASSYYREPQHFGD | 1-5 | Minor |
27 | 13 | ASSYTFQGETQY | 2-5 | Minor |
54 | 13 | ASSYTFQGETQY | 2-5 | 29 |
27 | 18 | ASSPGTGLDGYTF | 1-2 | Minor |
49 | 1 | ASSPGTGRNQPQHFGD | 1-5 | 89 |
50 | 13 | ASRDGAGEQYF | 2-7 | Minor |
28 | 13 | ASRDRAGN | 2-6 | Minor |
44 | 21 | ASRSGTGAHEQYF | 2-7 | Minor |
28 | 13 | ASRSGTGSYNEQFF | 2-1 | Minor |
23 | 3 | ASSGEETQYF | 2-3 | Minor |
33 | 18 | ASSGETDTQYF | 2-3 | Minor |
62* | 13 | ASSLAGGPDTQYF | 2-3 | Minor |
47 | 6 | ASSLAGTGGGEQYF | 2-7 | Minor |
47 | 6 | ASSLAGTSSTDTQYF | 2-3 | Minor |
35 | 6 | ASSLGSYNSPQHFDG | 1-5 | Minor |
63* | 21 | ASSLGSYNSPLH | 1-6 | Minor |
62* | 13 | ASSLLKPTSDTQYF | 2-3 | Minor |
12 | 14 | ASSLLTKTGSYEQYF | 2-7 | 81 |
35 | 6 | ASSLVGDPGELF | 2-2 | Minor |
47 | 6 | ASSLVGGRPSYNEQFF | 2-1 | Minor |
27 | 18 | ASSPPVRARDTQYF | 2-3 | Minor |
33 | 18 | ASSPPVRSRAQY | 2-5 | Minor |
18 | 17 | ASSWGGAGELFF | 2-2 | Minor |
29 | 5 | ASSWGGRGEQFF | 2-1 | Minor |
65* | 15 | ATSDLGQGASGELF | 2-2 | Minor |
47 | 15 | ATSDLGQQETQY | 2-5 | Minor |
42 | 15 | ATSDLGEKVGNEQFF | 2-1 | Minor |
47 | 24 | ATSRDLAGEKLF | 1-4 | Minor |
35 | 24 | ATSRDLASGRETQYF | 2-3 | Minor |
47 | 24 | ATSRDLRGEKLF | 1-4 | Minor |
41 | 24 | ATSRDLRTQETQY | 2-5 | Minor |
Patient . | VB . | CDR3 . | JB . | % clonal frequency . |
---|---|---|---|---|
27 | 13 | ASSVPGGEQYF | 2-7 | Minor |
50 | 13 | ASSVPGGEQYF | 2-7 | 48 |
54 | 13 | ASSVPGGEQYF | 2-7 | 43 |
27 | 13 | ASSYYREPQHFGD | 1-5 | Minor |
50 | 13 | ASSYYREPQHFGD | 1-5 | Minor |
27 | 13 | ASSYTFQGETQY | 2-5 | Minor |
54 | 13 | ASSYTFQGETQY | 2-5 | 29 |
27 | 18 | ASSPGTGLDGYTF | 1-2 | Minor |
49 | 1 | ASSPGTGRNQPQHFGD | 1-5 | 89 |
50 | 13 | ASRDGAGEQYF | 2-7 | Minor |
28 | 13 | ASRDRAGN | 2-6 | Minor |
44 | 21 | ASRSGTGAHEQYF | 2-7 | Minor |
28 | 13 | ASRSGTGSYNEQFF | 2-1 | Minor |
23 | 3 | ASSGEETQYF | 2-3 | Minor |
33 | 18 | ASSGETDTQYF | 2-3 | Minor |
62* | 13 | ASSLAGGPDTQYF | 2-3 | Minor |
47 | 6 | ASSLAGTGGGEQYF | 2-7 | Minor |
47 | 6 | ASSLAGTSSTDTQYF | 2-3 | Minor |
35 | 6 | ASSLGSYNSPQHFDG | 1-5 | Minor |
63* | 21 | ASSLGSYNSPLH | 1-6 | Minor |
62* | 13 | ASSLLKPTSDTQYF | 2-3 | Minor |
12 | 14 | ASSLLTKTGSYEQYF | 2-7 | 81 |
35 | 6 | ASSLVGDPGELF | 2-2 | Minor |
47 | 6 | ASSLVGGRPSYNEQFF | 2-1 | Minor |
27 | 18 | ASSPPVRARDTQYF | 2-3 | Minor |
33 | 18 | ASSPPVRSRAQY | 2-5 | Minor |
18 | 17 | ASSWGGAGELFF | 2-2 | Minor |
29 | 5 | ASSWGGRGEQFF | 2-1 | Minor |
65* | 15 | ATSDLGQGASGELF | 2-2 | Minor |
47 | 15 | ATSDLGQQETQY | 2-5 | Minor |
42 | 15 | ATSDLGEKVGNEQFF | 2-1 | Minor |
47 | 24 | ATSRDLAGEKLF | 1-4 | Minor |
35 | 24 | ATSRDLASGRETQYF | 2-3 | Minor |
47 | 24 | ATSRDLRGEKLF | 1-4 | Minor |
41 | 24 | ATSRDLRTQETQY | 2-5 | Minor |
VB indicates variable beta family; CDR3, complementarity-determining region 3; JB, joining beta family with first 3 variant AAs; minor, nonexpanded (single) clonotype.
Italics indicate identical AAs.
Patients in whom a major “immunodominant” clonotype was not determined, therefore not included in Table 1.